Abstract
Background:
Selective serotonin reuptake inhibitors (SSRIs) are increasingly used for depression and anxiety, with some studies suggesting they may impair bone mineral density and fracture healing. This study aims to investigate the impact of SSRIs on ankle and hindfoot open reduction and internal fixation (ORIF) outcomes.
Methods:
A retrospective review of the TriNetX database (2005-2023) identified patients undergoing ORIF for ankle, talus, calcaneus, or pilon fractures. Two cohorts were created: those with an active SSRI prescription at least 3 months prior to surgery and those without an SSRI prescription. Propensity score matching (1:1) adjusted for demographics, comorbidities, procedure type, and open fracture status, yielding 12 612 patients per cohort. Mean age was 52.3 vs 52.3 years, body mass index 31.8 vs 31.1, and follow-up 947 vs 880 days for SSRI and control groups, respectively.
Results:
At 6 months postoperatively, the SSRI cohort demonstrated significantly increased risks of readmission (risk ratio [RR] 1.155, 95% CI 1.043-1.278,
Conclusion:
Preoperative SSRI use was associated with increased medical and surgical complications after ankle and hindfoot ORIF, warranting further investigation and perioperative risk counseling.
This is a visual representation of the abstract.
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
